Cellular STAT3 Functions via PCBP2 To Restrain Epstein-Barr Virus Lytic Activation in B Lymphocytes

A major hurdle to killing Epstein-Barr virus (EBV)-infected tumor cells using oncolytic therapy is the presence of a substantial fraction of EBV-infected cells that does not support the lytic phase of EBV despite exposure to lytic cycle-promoting agents. To determine the mechanism(s) underlying this...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Virol
Autores principales: Koganti, Siva, Clark, Carissa, Zhi, Jizu, Li, Xiaofan, Chen, Emily I., Chakrabortty, Sharmistha, Hill, Erik R., Bhaduri-McIntosh, Sumita
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society for Microbiology 2015
Materias:
Virus-Cell Interactions
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4403452/
https://ncbi.nlm.nih.gov/pubmed/25717101
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.00121-15
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares